Interleukin 7 Receptor Control of T Cell Receptor Gamma Gene Rearrangement: Role of Receptor-associated Chains and Locus Accessibility
Overview
General Medicine
Affiliations
VDJ recombination of T cell receptor and immunoglobulin loci occurs in immature lymphoid cells. Although the molecular mechanisms of DNA cleavage and ligation have become more clear, it is not understood what controls which target loci undergo rearrangement. In interleukin 7 receptor (IL-7R)alpha-/- murine thymocytes, it has been shown that rearrangement of the T cell receptor (TCR)-gamma locus is virtually abrogated, whereas other rearranging loci are less severely affected. By examining different strains of mice with targeted mutations, we now observe that the signaling pathway leading from IL-7Ralpha to rearrangement of the TCR-gamma locus requires the gammac receptor chain and the gammac-associated Janus kinase Jak3. Production of sterile transcripts from the TCR-gamma locus, a process that generally precedes rearrangement of a locus, was greatly repressed in IL-7Ralpha-/- thymocytes. The repressed transcription was not due to a lack in transcription factors since the three transcription factors known to regulate this locus were readily detected in IL-7Ralpha-/- thymocytes. Instead, the TCR-gamma locus was shown to be methylated in IL-7Ralpha-/- thymocytes. Treatment of IL-7Ralpha-/- precursor T cells with the specific histone deacetylase inhibitor trichostatin A released the block of TCR-gamma gene rearrangement. This data supports the model that IL-7R promotes TCR-gamma gene rearrangement by regulating accessibility of the locus via demethylation and histone acetylation of the locus.
T Cell Development: From T-Lineage Specification to Intrathymic Maturation.
Golzari-Sorkheh M, Yoganathan K, Chen E, Singh J, Zuniga-Pflucker J Adv Exp Med Biol. 2025; 1471:81-137.
PMID: 40067585 DOI: 10.1007/978-3-031-77921-3_4.
Food for thought: Nutrient metabolism controlling early T cell development.
Werlen G, Hernandez T, Jacinto E Bioessays. 2024; 47(1):e2400179.
PMID: 39504233 PMC: 11662157. DOI: 10.1002/bies.202400179.
Kuo J, Wu H, Tung C, Huang W, Lin C, Wang C Chem Res Toxicol. 2024; 37(9):1488-1500.
PMID: 39141674 PMC: 11409377. DOI: 10.1021/acs.chemrestox.4c00060.
Advances in IL-7 Research on Tumour Therapy.
Fu C, Zhang X, Zhang X, Wang D, Han S, Ma Z Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675377 PMC: 11054630. DOI: 10.3390/ph17040415.
The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance.
OConnor K, Kishimoto K, Kuzma I, Wagner K, Selway J, Roderick J Leukemia. 2024; 38(5):951-962.
PMID: 38553571 PMC: 11073972. DOI: 10.1038/s41375-024-02232-8.